506 studies found for:    Open Studies | "Ovarian Diseases"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Ovarian Diseases"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Cancer Screening Program for Women at High Risk for Developing Ovarian Cancer
Conditions: Ovarian Diseases;   Ovarian Neoplasms
Interventions: Other: Laboratory Tumor Marker Analysis;   Other: Transvaginal Ultrasound;   Other: Health Status Questionnaire
2 Not yet recruiting Mediterranean Diet Versus Hypocaloric Diet in PCOS
Condition: Polycystic Ovary Syndrome
Interventions: Other: mediterranean diet, restricted calorie;   Other: hypocaloric diet, restricted calorie
3 Recruiting Low Dose Cyclophosphamide +/-- Nintedanib in Advanced Ovarian Cancer
Conditions: Ovarian Cancer;   Fallopian Tube Cancer
Intervention: Drug: BIBF 1120
4 Not yet recruiting Mediterranean Diet as Treatment for Normal Weight Women With PCOS
Condition: Polycystic Ovary Syndrome
Interventions: Other: mediterranean diet;   Other: normocaloric diet
5 Recruiting Clinical, Genetic, Behavioral, Laboratory and Epidemiologic Characterization of Individuals and Families at High Risk of Breast/Ovarian Cancer
Conditions: Familial Ovarian Cancer;   Familial Breast Cancer;   BRCA1-associate Malignancies;   BRCA2-associated Malignancies
Intervention:
6 Recruiting Surgery and Chemotherapy With or Without Chemotherapy After Surgery in Treating Patients With Ovarian, Fallopian Tube, Uterine, or Peritoneal Cancer
Conditions: Recurrent Endometrial Carcinoma;   Recurrent Fallopian Tube Cancer;   Recurrent Ovarian Epithelial Cancer;   Recurrent Primary Peritoneal Cavity Cancer;   Stage IIIA Endometrial Carcinoma;   Stage IIIA Fallopian Tube Cancer;   Stage IIIA Ovarian Epithelial Cancer;   Stage IIIA Primary Peritoneal Cavity Cancer;   Stage IIIB Endometrial Carcinoma;   Stage IIIB Fallopian Tube Cancer;   Stage IIIB Ovarian Epithelial Cancer;   Stage IIIB Primary Peritoneal Cavity Cancer;   Stage IIIC Endometrial Carcinoma;   Stage IIIC Fallopian Tube Cancer;   Stage IIIC Ovarian Epithelial Cancer;   Stage IIIC Primary Peritoneal Cavity Cancer;   Stage IV Fallopian Tube Cancer;   Stage IV Ovarian Epithelial Cancer;   Stage IV Primary Peritoneal Cavity Cancer;   Stage IVA Endometrial Carcinoma;   Stage IVB Endometrial Carcinoma
Interventions: Procedure: therapeutic conventional surgery;   Drug: cisplatin;   Drug: carboplatin;   Drug: paclitaxel;   Drug: pegylated liposomal doxorubicin hydrochloride;   Drug: gemcitabine hydrochloride;   Procedure: quality-of-life assessment;   Other: laboratory biomarker analysis
7 Recruiting Vargatef in Addition to First Line Chemotherapy With Interval Debulking Surgery in Patients With Ovarian Cancer
Condition: Ovarian Cancer
Interventions: Drug: vargatef;   Drug: placebo
8 Unknown  Efficacy Study of Neoadjuvant Chemotherapy to Treat Advanced Ovarian Cancer
Condition: Advanced Ovarian Cancer
Interventions: Drug: Neoadjuvant chemotherapy;   Drug: Carboplatin
9 Recruiting Phase I Study of the Oral PI3kinase Inhibitor BKM120 or BYL719 and the Oral PARP Inhibitor Olaparib in Patients With Recurrent Triple Negative Breast Cancer or High Grade Serous Ovarian Cancer
Conditions: Ovarian Cancer;   Breast Cancer
Interventions: Drug: BKM120 and Olaparib;   Drug: BYL719 and Olaparib
10 Recruiting Fallopian Tube Removal as a Method of Ovarian Cancer Prevention: A Descriptive Study
Condition: Ovarian Cancer
Intervention:
11 Recruiting A Study to Evaluate the Safety and Antitumor Activity in Subjects With Advanced Solid Tumors
Conditions: Advanced Solid Tumors;   Advanced Recurrent Ovarian Tumors
Interventions: Drug: MEDI3617;   Drug: MEDI3617 + Bev Q3W Dose Escalation;   Drug: MEDI3617 + Bev Q2W Dose Escalation;   Drug: Optional Dose Expansion;   Drug: MEDI3617 + Weekly Pax Dose Escalation;   Drug: MEDI3617 + Pax & Carbo Q3W Dos Esc;   Drug: MEDI3617 + Gem & Carbo Q3W Dos Esc;   Drug: Advanced Recurrent Ovarian Tumors
12 Recruiting Bevacizumab Beyond Progression in Platinum Sensitive Ovarian Cancer
Condition: Recurrent Ovarian Cancer
Interventions: Drug: Bevacizumab;   Drug: Paclitaxel;   Drug: Carboplatin;   Drug: pegylated liposomal doxorubicin;   Drug: Gemcitabine
13 Recruiting Paleo Versus Healthy ADA Diets for Treatment of Polycystic Ovarian Syndrome (PCOS)
Condition: Polycystic Ovarian Syndrome
Interventions: Other: Paleolithic diet;   Other: American Diabetes Association diet
14 Recruiting Evaluation of Adrenal Androgens in Normal and Obese Girls After Suppression and Stimulation
Conditions: Hyperandrogenemia;   Polycystic Ovary Syndrome;   Obesity
Interventions: Drug: Dexamethasone;   Drug: Cortrosyn
15 Recruiting Lavage of the Uterine Cavity for the Diagnosis of Ovarian and Tubal Carcinoma and Their Premalignant Changes.
Condition: Ovarian Epithelial Cancer
Interventions: Procedure: Lavage of the Cavum uteri and proximal fallopian tubes;   Procedure: Liquid-PAP smear
16 Recruiting DICER1-related Pleuropulmonary Blastoma Cancer Predisposition Syndrome: A Natural History Study
Conditions: Pleuropulmonary Blastoma;   Cystic Nephroma;   Ovarian Sertoli-Leydig Cell Tumors;   Ocular Medulloepithelioma;   Nasal Chondromesenchymal Hamartoma
Intervention:
17 Unknown  Premature Ovarian Failure (Genetic and Physiopathologic Analysis)
Condition: Premature Ovarian Failure
Intervention:
18 Recruiting Efficacy and Safety of Belotecan or Topotecan in Patients With Recurrent or Refractory Ovarian Cancer
Condition: Epithelial Ovarian Cancer
Interventions: Drug: Topotecan;   Drug: Belotecan
19 Recruiting Effect of Obstructive Sleep Apnea Syndrome on Insulin Sensitivity and Cardiovascular Risk in PCOS Adolescents
Conditions: Obstructive Sleep Apnea Syndrome;   Polycystic Ovary Syndrome;   Sleep Apnea
Intervention: Device: Nasal Continuous positive airway pressure (CPAP)
20 Recruiting Capturing BRCA1/2 Mutational Status in Women With High Grade Serous Ovarian Cancer and Impact on Clinical Outcome.
Condition: Ovarian Cancer
Intervention: Genetic: BRCA genetic data

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years